Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.

Green CJ, Johnson D, Amin HD, Sivathondan P, Silva MA, Wang LM, Stevanato L, McNeil CA, Miljan EA, Sinden JD, Morten KJ, Hodson L.

Am J Physiol Endocrinol Metab. 2015 Sep 15;309(6):E511-22. doi: 10.1152/ajpendo.00594.2014. Epub 2015 Jun 30.

2.

Immortalized human fetal retinal cells retain progenitor characteristics and represent a potential source for the treatment of retinal degenerative disease.

Hasan SM, Vugler AA, Miljan EA, Sinden JD, Moss SE, Greenwood J.

Cell Transplant. 2010;19(10):1291-306. doi: 10.3727/096368910X505477. Epub 2010 May 4.

PMID:
20447347
3.

Stem cell treatment of ischemic brain injury.

Miljan EA, Sinden JD.

Curr Opin Mol Ther. 2009 Aug;11(4):394-403. Review.

PMID:
19649984
4.

c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain.

Stevanato L, Corteling RL, Stroemer P, Hope A, Heward J, Miljan EA, Sinden JD.

BMC Neurosci. 2009 Jul 21;10:86. doi: 10.1186/1471-2202-10-86.

5.

Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line.

Thomas RJ, Hope AD, Hourd P, Baradez M, Miljan EA, Sinden JD, Williams DJ.

Biotechnol Lett. 2009 Aug;31(8):1167-72. doi: 10.1007/s10529-009-9989-1. Epub 2009 Apr 3.

PMID:
19343502
6.

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AY, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, Heales S, Duchen MR, Latchman D, Tabrizi SJ, Wood NW.

PLoS One. 2008 Jun 18;3(6):e2455. doi: 10.1371/journal.pone.0002455. Erratum in: PLoS ONE. 2008;3(7). doi: 10.1371/annotation/17d5aaa1-c6d8-4aad-a9a4-56b2c1220c83. Abramov, Andrey S Y [corrected to Abramov, Andrey Y]. PLoS ONE. 2008;3(7). doi: 10.1371/annotation/ba489c2a-5cf2-481c-aff7-d2c8c4ecdcfa.

7.

Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease.

Miljan EA, Hines SJ, Pande P, Corteling RL, Hicks C, Zbarsky V, Umachandran M, Sowinski P, Richardson S, Tang E, Wieruszew M, Patel S, Stroemer P, Sinden JD.

Stem Cells Dev. 2009 Mar;18(2):307-19. doi: 10.1089/scd.2008.0078.

PMID:
18554088
8.

Differential development of neuronal physiological responsiveness in two human neural stem cell lines.

Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD.

BMC Neurosci. 2007 May 25;8:36.

9.

Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.

Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC.

Brain Res. 2004 Aug 6;1016(2):170-81.

PMID:
15246853
10.

Regulation of growth factor receptors by gangliosides.

Miljan EA, Bremer EG.

Sci STKE. 2002 Nov 26;2002(160):re15. Review.

PMID:
12454318
11.

Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.

Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG.

J Biol Chem. 2002 Mar 22;277(12):10108-13. Epub 2002 Jan 16.

Supplemental Content

Loading ...
Support Center